en
Scientific article
Review
Open access
English

Implications of somatostatin analogues in the treatment of acromegaly

Published inEuropean endocrinology, vol. 9, no. 2, p. 132-135
Publication date2013
Abstract

Octreotide has an important role in the medical management of acromegaly. Its place in the management of acromegaly as an adjuvant therapy after neurosurgery is well established with a well-demonstrated efficacy. It can also be used in certain clinical conditions as a neoadjuvant treatment. Clinicians and patients should be aware of the possible side effects of octreotide treatment.

Keywords
  • Acromegaly
  • Octreotide
  • Side effects
  • Somatostatin analogues
  • Treatment
Citation (ISO format)
GARIANI, Karim, MEYER, Patrick, PHILIPPE, Jacques. Implications of somatostatin analogues in the treatment of acromegaly. In: European endocrinology, 2013, vol. 9, n° 2, p. 132–135. doi: 10.17925/EE.2013.09.02.132
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1758-3772
313views
163downloads

Technical informations

Creation08/11/2020 10:56:00 AM
First validation08/11/2020 10:56:00 AM
Update time03/15/2023 10:45:24 PM
Status update03/15/2023 10:45:24 PM
Last indexation01/17/2024 11:06:34 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack